JP1701743S - - Google Patents

Info

Publication number
JP1701743S
JP1701743S JPD2021-4930F JP2021004930F JP1701743S JP 1701743 S JP1701743 S JP 1701743S JP 2021004930 F JP2021004930 F JP 2021004930F JP 1701743 S JP1701743 S JP 1701743S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2021-4930F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2021-4930F priority Critical patent/JP1701743S/ja
Priority to US29/805,712 priority patent/USD1037006S1/en
Priority to TW110304617F priority patent/TWD218270S/zh
Application granted granted Critical
Publication of JP1701743S publication Critical patent/JP1701743S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2021-4930F 2021-03-10 2021-03-10 Active JP1701743S (enExample)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JPD2021-4930F JP1701743S (enExample) 2021-03-10 2021-03-10
US29/805,712 USD1037006S1 (en) 2021-03-10 2021-08-30 Packaging container
TW110304617F TWD218270S (zh) 2021-03-10 2021-09-02 包裝用容器

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2021-4930F JP1701743S (enExample) 2021-03-10 2021-03-10

Publications (1)

Publication Number Publication Date
JP1701743S true JP1701743S (enExample) 2021-12-06

Family

ID=78815309

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2021-4930F Active JP1701743S (enExample) 2021-03-10 2021-03-10

Country Status (3)

Country Link
US (1) USD1037006S1 (enExample)
JP (1) JP1701743S (enExample)
TW (1) TWD218270S (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1051722S1 (en) * 2022-09-14 2024-11-19 INA International Ltd. Beverage container

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD431969S (en) * 1999-11-29 2000-10-17 Pacific Market, Inc. Thermal beverage bottle
USD521383S1 (en) * 2003-10-10 2006-05-23 The Boots Company Plc Container
USD521384S1 (en) * 2003-10-10 2006-05-23 The Boots Company Container
USD516436S1 (en) * 2004-08-27 2006-03-07 The Procter & Gamble Company Container
CA129652S (en) * 2008-09-05 2009-10-02 Unilever Plc Container for personal care products
TWD144109S1 (zh) * 2010-11-24 2011-12-01 愛茉莉太平洋股份有限公司 化妝品容器(六十四)
USD902738S1 (en) * 2015-12-04 2020-11-24 Gensco Laboratories Llc Tamper proof safety container
USD854939S1 (en) * 2017-02-13 2019-07-30 Birkenstock Sales GmbH Bottle for cosmetics
JP1613516S (enExample) * 2017-11-10 2018-09-10
USD875546S1 (en) * 2018-06-19 2020-02-18 Yonwoo Co., Ltd. Container for packaging cosmetics
USD891927S1 (en) * 2019-08-08 2020-08-04 Ningbo SKL International Co., LTD Capsule bottle
JP1671186S (enExample) * 2020-03-26 2020-10-26
JP1671146S (enExample) * 2020-03-26 2020-10-26

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1051722S1 (en) * 2022-09-14 2024-11-19 INA International Ltd. Beverage container

Also Published As

Publication number Publication date
USD1037006S1 (en) 2024-07-30
TWD218270S (zh) 2022-04-11

Similar Documents

Publication Publication Date Title
BR102021007058A2 (enExample)
BR102020022030A2 (enExample)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134206A1 (es) Degradantes y usos de los mismos
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos
AR134176A1 (es) VARIANTES DEL DOMINIO Fc CON UNIÓN MEJORADA AL RECEPTOR Fc